Topic Listing for Emergent Biosolutions

Accessways Accordance Clause 5131 Such Dispute Shall Resolved 513
Accounting Assets Acquired Liabilities Assumed Business Combination Arise Accounting Collaborative Arrangements
Accounting Creditors Impairment Loan Accounting Defensive Intangible Asset
Accounting Defensive Intangible Assets Accounting Derivatives Hedging Activities
Accounting Equity Instruments Issued Other Employees Acquiring Conjunction Accounting Impairment Disposal Long-lived Assets
Accounting Income Taxes Accounting Instrument Embedded Feature Settlement Amount Based Stock
Accounting Nonrefundable Advance Payments Goods Services Received Future Accounting Research Development Costs
Accounting Revenue Arrangements Multiple Deliverables Accounting Stock Issued Employees
Accounting Stock-based Compensation Accounting Stock-based Compensation-transition Disclosures
Accounting Uncertainty Income Taxes Interpretation Fasb Statement 109 Accounts Receivable
Accrued Expenses Acknowledgements Representations
Acquire Additional Late-stage Product Candidates Actual Net Sales
Add Route Administration Additional Access
Additional Anthrax Vaccine Developments Additional Information
Additional Reports Addition Quarterly Annual Referred Clause 5101 Additional Risks Related Sales Biodefense Products Government
Adjustments Adjustments Changes Common Stock Certain Other Events
Administration Adolescent Indication
Adolescent Marketing Approval Advanced Understandings
Aeras Aeras Agreement
Affiliate Affiliate Person
Affiliates Affirmative Covenants
Agreement Agreements East West Resources Corporation
Agreements Intergen Airplane Charter Simba Llc
Ame Title Position Amended Restated Marketing Agreement
Amendment Amendment Termination
Amendments Amendments Fasb Interpretation
Annual Meeting Stockholders Held Anthracis
Anthrasis Anthrax
Anthrax Immune Globulin Anthrax Monoclonal
Anthrax Therapies Anthrax Vaccines
Anticipated Delivery Schedule Appendices
Appendix Delivery Schedule Applicability Fasb Statement Business Combinations Accounted Purchase Method
Applicable Law Application Proceeds
Are-qrs Corp Arpi Llc
Assignment Assistance Needed Locate Small Business Sources
Assumption Assumptions
Attached Check Audit Committee
Audit Committee Financial Expert Audit Committee Report
Audits Site Visits Authorised Guarantee Agreement
Authorized Contacts Available Information
B44 Pricing Doses Biothrax Clins 0004 0004a B47 Cancellation Ceiling Fee Clin 0009
Baccillus Anthracis Bacillus Anthracis
Background Bancorp
Bank Bankrupt
Base Licensed Product Base Prices
Base Salary Basis Presentation Consolidation
Beneficial Ownership Reporting Compliance Benefits
Between Biodefense
Biodefense Business Biodefense Market
Biologika Llc Biopharm Llc
Biopharm Shares Biothrax
Biothrax Anthrax Vaccine Adsorbed Biothrax Development Activities
Biothrax Immune Related Biologics Product Candidates Complex Manufacture Biothrax Immunobiotic Product Candidates Complex Manufacture Especially Large
Biothrax Lot Release Fda Review Biothrax Product Liability Litigation
Biothrax Vaccine Immune-related Therapeutic Product Candidates Complex Manufacture Biothrax Vaccine Therapeutic Product Candidates Complex Manufacture Ship
Biovac Llc Board Committees
Board Determination Independence Board Directors Hopes Stockholders Attend Annual
Board Directors Meetings Attendance Board Recommendation
Boards Authority Amend Bold Enlarge
Botulinum Botulinum Vaccines
Botulism Brief Description Supplies Services
Broker Build Large Scale Manufacturing Infrastructure
Business Business Adversely Affected Negative Audit Government
Business Combinations Business Depends Significantly Success Completing Development Commercialization Product
Business Harmed Not Adequately Forecast Customer Demand Business Harmed Result Government Contracting Process Competitive Bidding
Business Relations Business Subject Audit Government Negative Adversely Affect
Capital Stock Capitalization Interest Cost
Capitalized Interest Capitalized Lease Obligation
Cash Equivalents Cash Flows
Centers Disease Control Certain Products Develop Eligible Reimbursement Medicaid State-specific Programs
Certain Risks Uncertainties Certification
Cfr Chapter Clauses Cgcp
Cgmp Chlamydia
Chlamydia Trachomatis Chlamydia Vaccine
Chlamydium Trachomatis Chlamydia Class Director Nominees Terms Expire 2010 Annual Meeting
Class Directors Terms Expire 2008 Annual Meeting Class Directors Terms Expire 2009 Annual Meeting
Classification Measurement Redeemable Securities Clause
Clinical Trials Clostridium Botulinum
Code Ethics Coli
Collaboration Collateral
Collateral Document Combination Product
Commercial Commercial Business
Commercial Market Commercial Products
Commercial Products Service Plan Commercial Success Biothrax Products Develop Depend Degree Market
Common Areas Common Stock
Communicating Independent Directors Compared 2006
Compensation Committee Compensation Committee Interlocks Insider Participation
Compensation Committee Report Compensation Directors
Compensation Opportunities Competitive Biotechnology Companies Similar Size Phase Competition
Competitors Able Obtain Orphan Drug Exclusivity Products Same Complement Organic Growth Strategic Mergers Acquisitions
Compliance Exchange Act Compliance Jul 1999
Compliance Laws Comprehensive Income
Comprehensive Income Loss Comptroller General Examination Record
Concentrations Credit Risk Conditions Precedent
Conducting Media Conference Call Webcast
Confidential Information Confidentiality Information
Conjunction Selling Goods Services Consent
Consent Ernst Young Llp Independent Registered Public Accounting Consent Guarantor
Consent Independent Registered Public Accounting Firm Considering Effects Prior Misstatements Quantifying Current Financial Statements
Consolidated Financial Statements Consolidation Variable Interest Entities
Consolidation Variable Interest Entities Interpretation Accounting Research Bulletin Consultant
Consulting Agreement Consulting Agreements
Consulting Services Agreement Contact Address
Contaminated Continue Develop Balanced Portfolio Immunobiotic Products
Contract Contract Communications Correspondence
Contract Deliverables Contract Objective
Contract Value Contracting Officer
Contracting Officer Check Appropriate Contractor Fails Make Good Faith Effort Comply Subcontracting
Contractor Review Contractor Shall Submit Copy Fda Approval Documentation Expiry
Contracts Contracts Grant Revenues
Contracts Grants Contracts Grants Revenue
Contracts Grants Revenues Control
Controlled Technology Controls
Corporate Governance Guidelines Correlate
Cost Control Cost Product Sales
Counterparts Facsimile Signature Creation Direct Financial Obligation Off-balance Sheet Arrangement
Critical Accounting Policies Estimates Current Rent
Customer Satisfaction Daniel Abdun-nabi
De-escalation Study Debt Coverage Ratio
Debt Financing Default
Defaults Senior Securities Definition Affiliate
Definitions Deliverables Reports
Deliveries Performance Demand Registration Rights
Denise Esposito Department Defense
Department Health Human Services Departure Directors Certain Officers Election Appointment Compensatory
Departure Directors Principal Officers Election Appointment Derived Substantially Revenue Sales Biothrax Contracts Dod Hhs
Derived Substantially Revenue Sales Biothrax Contracts Hhs Dod Description Benefits Biothrax
Description Development Status Description Good Faith Effort
Developed World Developing World
Developing World Distributor Development
Development Plan Director Compensation
Director Nomination Process Director Nominees
Directors Directors Executive Officers
Directors Nominees Disclosures Derivative Instruments Hedging Activities-an Amendment Fasb Statement
Discretionary Annual Cash Bonuses Disease Overview
Dispute Resolution Disruption Damage Destruction Manufacturing Facilities Impede Ability Manufacture
Dissemination Information Dividend Policy
Documents Incorporated Reference Dod
Domestic International Marketing Don Elsey
Duties Earnings Per Share
Ebi Ebsi
Eea Effective 2007
Effective Date Effects Inflation
Efforts Elements Executive Compensation
Eligibility Receive Awards Eligible Account
Emergent Emergent Biodefense Operations
Emergent Biodefense Operations Lansing Inc Emergent Biosolutions Inc
Emergent Biosolutions Reports Financial Results 2008 Emergent Biosolutions Reports Financial Results 2009
Emergent Biosolutions Reports Financial Results Full 2008 Emergent Combination Product
Emergent Data Emergent Europe Limited
Emergent Expenses Emergent Manufacturing Technology
Emergent Odp Technology Emergent Parents Contact Address
Emergent Product Development Gaithersburg Inc Emergent Regulatory Documents
Emergent Seed Stock Emergents Contact Address
Employee Relationship Employment Agreements
Enabling Parties End User
Enterprise Resource Planning System Entry Material Definitive Agreement
Environmental Law Environmental Laws
Equitable Opportunity Equity Compensation Plan Information
Equity Compensation Program Align Executive Interests Those Stockholders Erisa
Estate Roads Estimates
Ethics Committee Evaluation Contractor Performance Service
Evaluators Evanston Insurance Bioport Corporation Robert Myers
Event Default Events Default Remedies
Exact Name Registrant Specified Charter Exchange Act 1934
Exchange Rights Excusable Delay
Executive Compensation Executive Compensation Principles
Executive Director Compensation Process Executive Director Compensation Processes
Executive Officers Registrant Executive Resignation
Executive Severance Arrangements Exhibits
Existing Data Existing Indebtedness
Expand Biodefense Franchise Expand Core Biologics Manufacturing Capabilities
Expect Require Additional Funding Unable Raise Capital Needed Expenses
Explanatory Export Control Technology
Extend Shelf Life Extension Right
Extension Term Face Substantial Competition Result Others Developing Commercializing Products
Fail Achieve Significant Sales Biothrax Customers Addition Government Fail Attract Keep Senior Management Key Scientific Personnel
Fail Comply Obligations Intellectual Property Licenses Parties Lose Fail Protect Intellectual Property Rights Harm Business
Fail Successfully Manage Acquisitions Ability Develop Product Candidates Failure Obtain Regulatory Approval International Jurisdictions Prevent Marketing
Fair Value Financial Instruments Fair Value Measurements
Fair Value Option Financial Assets Liabilities-including Amendment Fasb Fast Track Designation
Fast Track Designation Biothrax Post-exposure Prophylaxis Against Anthrax Fast Track Designation Biothrax Post-exposure Prophylaxis Anthrax Infection
Fast Track Designation Product Candidates Not Actually Lead Fcpa
Fda Federal Acquisition Regulation Far Cfr Chapter Clauses
Federal Income Tax Consequences Fifth Bank
Fifth Loan Fifth Loan Documents
Fifth Schedule Filling Services Agreement
Final Report Interim Financial Condition Liquidity
Financial Expectations Financial Outlook
Financial Outlook 2008 Financial Statement Schedules
Financial Statements Financial Statements Exhibits
Financial Statements Follow Fixtures
Flip-in Event Flip-over Event
Floor Space Flow Down Clause
Focus Core Capabilities Product Development Manufacturing Following Specific Information Provided Offeror Pertaining Project Director
Force Majeure Foreign Currencies
Foreign Governments Tend Impose Strict Price Controls Adversely Foreign Regulation
Form 10-k Form 10-k Amendment
Form 10-q Former Shareholders Microscience Investments Limited
Frederick Maryland Fte Numbers
Ftta Fuad El-hibri
Fuad El-hibri Age Became Director 2004 Fuad El-hibri Chief Executive Officer Chairman Board Directors
Full Reinstatement Value Fund Product Development Through Internally-generated Cashflows
Funding Requirements Further
G10 Notification Utilization Gaap
General General Counsel Secretary
General Provisions Goals
Governing Law Government Contract Biothrax Requires Ongoing Funding Decisions Failure
Government Contracts Government Contracts Biothrax Require Annual Funding Decisions Failure
Government Contracts Biothrax Require Ongoing Funding Decisions Failure Government Indemnification
Government Regulation Grants Option Awards Directors
Grants Plan-based Awards Gross Sales
Group Streptococcus Vaccine Grow Immune-related Product Pipeline Using Platform Technologies
Guarantor Guaranty
Guide Guide Care Agricultural Animals Research Teaching
Guide Care Laboratory Animals H10 Protection Human Subjects
H11 Information Compliance Animal Care Requirements H12 Requirements Adequate Assurance Protection Vertebrate Animal Subjects
H13 Care Live Vertebrate Animals H14 Approval Required Assurance Olaw
H15 Liability Protection Prep Act H16 Manufacturing Standards
H17 Prohibition Contractor Involvement Terrorist Activities H18 Hhsar 352270-5 Key Personnel Apr 1984
H19 Registration Select Agent Program Work Involving Possession Hauer Group
Hazardous Materials Hazardous Materials Chemicals Bacteria Viruses Requires Comply Regulatory
Hazardous Materials Select Agents Hazardous Substance
Held 2008 Hepatitis
Hepatitis Therapeutic Vaccine Hhs
Hierarchy Generally Accepted Accounting Principles Hierarchy Generally Accepted Accounting Principles-a Replacement Fasb Statement
Highlights Hiv Marketing Approval
However Order Ensure Quorum Present Meeting Please Complete Hpa Agreements
Htipsosdhhsgov Http Wwwgpoaccessgov Cfr Indexhtml
Https Wwwtheconferencingservicecom Prereg Keyprocesskeyp3qnb6ndy Https Wwwtheconferencingservicecom Prereg Keyprocesskeyp6pjfe9ut
Humanitarian Organisation Identification Disposition Data
Idt Immune Globulins
Immune System Impairment Long-lived Assets
Important Information Procedures Opening New Account Important Notice Regarding Availability Proxy Materials Annual Meeting
Improvement Improvement Rent
Incentive Stock Options Incidental Registration Rights
Income Taxes Incorporation Technical Proposal
Increase Expansion Space Base Rent Indebtedness
Indebtedness Limit Cash Flow Available Invest Ongoing Needs Indemnification Limitation Liability
Independence Discussions Audit Committees Independent Director
Independent Registered Public Accounting Firms Fees Index
Index Form 10-q Index Rate
Indications Individual Plan
Infant Indication Infant Marketing Approval
Infant Phase Iib Study Information Relating Equity Awards Holdings
Information Relating Grants Plan-based Awards Information Relating Option Exercises
Information Relating Outstanding Equity Awards Infringe Alleged Intellectual Property Rights Parties Adversely Affect
Initial Initial Rent
Initiated Manufacturing Facility Expansion Program Delays Completing Receiving Inspection Acceptance
Inspection Acceptance 1999 Insurance Coverage Litigation
Insurance Policies Not Adequate Compensate Liabilities Incur Event Insurance Policies Not Adequately Compensate Liabilities Incur Event
Insured Risks Intellectual Property Licenses
Intellectual Property Rights Intentionally Left Blank
Intercreditor Agreement Internal Control Over Financial Reporting
Internal Control-integrated Framework Internet Availability Proxy Materials
Interpretation Fasb Statement 109 Accounting Income Taxes Interpretation Fasb Statement 109 Accounting Income Taxes Fin
Intervac Llc Intervac Management Llc
Invention Inventories
Inventors Investors
Investors Contact Investors Media Contact
Invoice Submission Isis Applications
Isis Licence Agreement Isr Ssr Shall Submitted Via Electronic Subcontracting Reporting
Jerome Hauer Age Became Director 2005 Joseph Allbaugh Age Became Director 2006
Key Countries Key Financial Results
Key Operational Accomplishments Know-how
Kyle Keese Laboratory License Requirements 1998
Landlord Lansing Inc
Lansing Michigan Laws Regulations Affecting Government Contracts Make Costly Difficult
Laws Regulations Governing International Operations Preclude Developing Manufacturing Lead Director
Lease Leases
Legal Proceedings Challenging Governments Biothrax Costly Defend Limit Legislation Contractual Provisions Limiting Restricting Liability Manufacturers Not
Legislation Regulation Related Bioterrorism Counteragents Pandemic Preparedness Lender
Lender Indebtedness Lender Information
Letters Credit Leverage Internal Manufacturing Capabilities Infrastructure
Liabilities Libor
Libor Index Rate Licence
License Agreements License Fee
License Fees Royalties Payment Other Income License Grant
Licensed Field Licensed Patent Technology
Licensed Product Licensed Technology
Licensee Licensee Performance
Licensor Licensor Combination Product
Licensors Director Licensors Representative
Lien Limitations Expenses
Limited Operating History Not Maintain Profitability Future Periods Liquidation
Liquidity Capital Resources List Subsidiaries
Litigation Against Protein Sciences Corporation Litigation Settlement
Loan Loan Agreement
Loan Document Loan Documents
Loans Louis Sullivan Age Became Director 2006
Lr111 Easements Granted Lease Benefit Property Lr112 Easements Granted Reserved Lease Over Property Benefit
Lr4 Property Malaysian Venture
Managements Discussion Analysis Financial Condition Results Operations Manufacture
Manufacturing Manufacturing Infrastructure
Manufacturing Process Manufacturing Technology
Market Market Information Holders
Market Opportunity Market Opportunity Current Treatment
Market Opportunity Current Treatments Marketing Agreement
Marketing Approval Marketing Authorisation
Marketing Plan Marketing Sales
Markings Master Plan
Master Seed Stock Material Adverse Effect
Matters Disregarded Maturity
Maximize Commercial Potential Biothrax Meaning Indexed Own Stock
Meaning Present Fairly Conformity Generally Accepted Accounting Principles Media Contact
Meningitis Vaccine Method Delivery
Michigan Biologic Products Inc Mil Vax Litigation
Milestone Fee Milestones Milestone Fees
Milvax Litigation Minority Interest Subsidiary
Miscellaneous Mitigate Costs Advancing Selected Pipeline Products Seeking Governmental
Monthly Report Meaning Set Out Clause 5102 Mortgage
Mrc Multivalent Product
Mva Platform Technology Mva85a
Mycobacterium Tuberculosis Myobacterium Tuberculosis
Name National Institute Allergy Infectious Diseases
Negative Covenants Negotiate Good Faith
Neisseria Meningitidis Net Loss Attributable Noncontrolling Interest
Net Sales Net Sales Actual
New Data New Rent
Next Generation Anthrax Vaccine Nominating Corporate Governance Committee
Non-commercial Non-key Patent Territories
Non-solicitation Noncontrolling Interest Consolidated Financial Statements
Noncontrolling Interests Consolidated Financial Statements Amendment Arb Nonstatutory Stock Options
Not Not Able Commercialize Product Candidates Preclinical Development Efforts
Not Able Obtain Orphan Drug Exclusivity Products Competitors Not Able Obtain Required Regulatory Approvals Commercialize Product
Not Anticipate Paying Cash Dividends Foreseeable Future Not Applicable
Not Intended Replace Existing Corporate Commercial Plan Extensive Not Maintain Profitability Future Periods Consistent Basis
Not Successful Maintaining Establishing Collaborations Adversely Affect Ability Notes
Notes Consolidated Financial Statements Notes Receivable
Notice Notice 2007 Annual Meeting Stockholders Held
Notice Prior Publication Now Therefore
Number Corresponds Rating Each Category See Attached Guidelines Oetc Agreement
Offeror Required Include Explanation Category Goal Officers
Omp Designation Ongoing Legal Proceedings Future Similar Lawsuits Limit Purchases
Ongoing Regulation Original
Original Guaranty Original Loan Agreement
Orphan Drugs Other
Other Biodefense Products Other Events
Other Executive Compensation Policies Other Information
Other Litigation Other Matters
Other Parties Other Product
Other Regulations Other Stock-based Units
Outside Legal Counsel Overall Development Plan
Overriding Aims Overview
Ownership Work Packaging
Parking Area Part
Part Other Information Particulars
Parties Parties Not Manufacture Product Candidates Products Sufficient Quantities
Parties Rely Clinical Trials Not Perform Contractually Required Party
Past Patent Costs Patent Enforcement Prosecution
Patent Rights Payment Electronic Funds Transfer Central Contractor Registration Oct
Payment Information Form Payment Services
Pbgc Performance Emergent Scientists Shall Ensure Conduct Activities
Performance Evaluation Factors Period Performance
Permitted Lien Permitted Liens
Permitted Part Person
Personnel Phase Clinical Trial
Phase Iib Clinical Trial Phase Iib Period
Place Method Delivery Plan
Plan Benefits Plan Was Reviewed
Planning Acts Point Practical Application
Point Practical Application Reports Policies Procedures Related Person Transactions
Political Social Factors Including Related Litigation Delay Impair Post-exposure Prophylaxis
Pre-approval Policies Procedures Pre-approval Policy Procedures
Preclinical Studies Preclinical Studies Ind
Preferred Stock Premises
Prescribed Rate President
President Emergent Press Releases
Prevalence Market Opportunity Current Treatment Pricing Fixed Price Government Contracts Based Estimates Time
Prime Rate Prior Agreement
Prior Rights Distribution Date Privacy Act Applicability Apr 2000
Privacy Act Statement Proceeds
Product Liability Lawsuits Cause Incur Substantial Liabilities Require Product Portfolio
Product Sales Product Sales Revenues
Products Products Develop Also Eligible Reimbursement Medicaid State-specific Programs
Products Subject Restrictions Withdrawal Market Penalties Fail Comply Professional Standards
Program Administrator Prohibition Appropriated Funds Lobbying Activities Jul 1999
Project Bioshield Project Identification Purpose
Project Officer Property
Property Plant Equipment Proposal
Proposal Approval Amended Restated Emergent Biosolutions Inc 2006 Proposal Election Directors
Proposal Ratification Selection Independent Registered Public Accounting Firm Protect Life
Protection Intellectual Property Rights Costly Fail Business Harmed Protein Report Substantially Conform Format Set Out Schedule
Provide Statement Level Effort Dedicated Resultant Contract Awarded Provided
Provisions Corporate Charter Documents Delaware Law Prevent Frustrate Public Funder
Public Readiness Emergency Preparedness Act Purchased In-process Research Development
Purification Emergent Shall Within Business Production Sufficient Protein Purpose
Quality Product Service Quantitative Qualitative Disclosures Market Risk
Qui Tam Rate Management Agreement
Rate Management Obligation Reasons Rights Agreement
Receivable Recent Accounting Pronouncements
Recent Sales Unregistered Securities Recitals
Reclassifications Recognition Measurement Financial Statements Business Enterprises
Recombinant Botulinum Vaccine Record Keeping
Redemption Rights Reduce Doses Pre-exposure Prophylaxis
Registered Public Accounting Firm Registrants Telephone Number Including Area Code
Registration Rights Regulation Immune Globulin Products
Regulations Regulations Regarding Government Contracting
Regulatory Approval Regulatory Authority
Regulatory Documents Reimbursable Out-of-pocket Expenses
Reimbursement Agreement Reimbursement Payment
Reimbursement Pricing Controls Related Party Transactions
Relationship Parties Release Contractor Performance Evaluation Information
Release Microscience Released Claims
Releasees Releasors
Relevant Date Rely Filling Biothrax Vials Unable Perform Services Business
Rely Property Equipment Owned Dod Manufacturing Process Biothrax Rely Property Equipment Owned Government Manufacturing Process Biothrax
Remainder Page Intentionally Left Blank Rent Credit
Rent Review Dates Rental Value
Reporting Comprehensive Income Reporting Cooperation
Reporting Matters Involving Fraud Waste Abuse Reporting Requirements
Reporting Revenue Gross Principal Versus Net Agent Reports Records
Representations Certifications Other Statements Offerors Jul 1999 Required Contract Type Fixed-price
Research Development Research Development Expense
Research Development Expenses Reservation Rights
Resolving Disagreements Between Government Contractor Restricted Cash
Restricted Stock Awards Restricted Stock Units
Results Operations Financial Condition Results Operations Financial Conditions
Retention Period Revenue Recognition
Revenues Revocation Proxy
Revolving Credit Revolving Credit Commitment
Revolving Credit Loans Revolving Line Credit
Rights Rights Distribution Date
Risks Related Acquisition Strategy Risks Related Commercialization
Risks Related Dependence Parties Risks Related Financial Position Need Additional Financing
Risks Related Intellectual Property Risks Related Manufacturing Facilities
Risks Related Regulatory Approvals Rockville 2007
Rockville 2008 Rockville 2009
Rockville Maryland 20850 Role Executive Officers Determining Compensation
Ronald Richard Age Became Director 2005 Rot
Royalty Rate Adjusted Accordance Clause Rule 14a-101
Safe Harbor Statement Safety Act
Safety Act Other Statutory Protections Salmonella
Salmonella Enterica Type Typhi Salmonella Typhi
Sanofi Pasteur Sarbanes-oxley Act 2002
Schedule Schedule 217 Additional Patents Patent Applications
Schedule 217 Existing Patents Schedule Affiliates Sublicensees
Schedule Data Schedule Infant Phase Iib Study Protocol
Schedule Net Sales Adjustment Multivalent Products Combination Schedule Overall Development Plan
Schmitttebsicom Scientific Background
Securities Authorized Issuance Equity Compensation Plans Securities Exchange Act 1934
Security Security Agreement
Security Plan Requirements Seed Stock
Seek Governmental Other Party Grants Support Selectively Establish Collaborations
Selling General Administrative Selling General Administrative Expenses
Seq Series Junior Participating Preferred Stock
Service Charge Service Charge Period
Service Description Services
Share Exchange Agreement Share-based Payment
Shares Shares Held Street Name Account Broker Bank Other
Shares Registered Directly Name Vote Sign Display
Signature Signature Page Follows
Signatures Signatures Appear Next Page
Significant Customers Accounts Receivable Significant Portion Each Senior Executives Compensation Variable Based
Significant Portion Total Outstanding Shares Restricted Immediate Resale Significant Portion Total Outstanding Shares Sold Market Near
Small Marketing Sales Group Unable Expand Capabilities Enter Small Sales Marketing Group Unable Expand Capabilities Enter
Solicitation Proxies Source Selection Information
Sources Liquidity Special Regarding Forward-looking Statements
Spi Status Rights Holder Tax Effects
Stock Appreciation Rights Stock Option Awards
Stock Ownership Requirements Hedging Policies Stock Price Volatile Purchasers Common Incur Substantial Losses
Stock-based Compensation Stockholder Arrangements
Stockholder Proposals Stockholder Ratification
Stockholder Rights Plan Prevent Change Control Instances Some Stockholders Sharing Same Address
Strategy Strategy Generating Growth Through Acquisitions Not Successful
Subcontracting Plan Subcontracting Plan Was Submitted
Subject Clause 5112 Emergent Shall Best Reasonable Efforts Sublicensee
Sublicensing Rights Submission Matters Vote Security Holders
Subsequent Events Subsidiary
Success Business Government Depends Compliance Additional Regulations Obligations Success Business Government Depends Compliance Regulations Obligations Contracts
Successful Completion Date Successors Assigns
Such Approval Recorded Accordance Clause Such Approval Recorded Accordance Clause Amendment Considered Major
Sue Bailey Age Became Director 2007 Summary Compensation
Summary Expected Activities Summary Potential Payments Termination Change Control
Supplemental Benefits Perquisites Limited Used Selectively Specific Circumstances Support Corporate Objectives
Table Contents Tax Benefits
Tax Consequences Taxes
Tenant Tenant Notices
Tenants Proportion Service Charge Term
Term Loan Term Termination
Termination Material Definitive Agreement Terms Expire 2010 Annual Meeting Class Directors
Terms Expire 2011 Annual Meeting Class Directors Terms Expire 2012 Annual Meeting Class Director Nominees
Territory Territory Fees
Timeliness Performance Timely Payments Subcontractors
Total Other Income Expense Trademark
Trial Success Criteria Tuberculosis
Tuberculosis Vaccine Types Awards
Typhella Typhi
Typhoid Vaccine Ucc Collateral
Unable In-license Intellectual Property Necessary Develop Manufacture Sell Unable Obtain Adequate Reimbursement Governments Party Payors Products
Unable Protect Confidentiality Proprietary Information Know-how Value Technology Unaffiliated Person
Undisputed Amount Unfavorable Provisions Government Contracts Harm Business Financial Condition
Unfavorable Provisions Government Contracts Some Customary Harm Business University
University Collaborators Unregistered Sales Equity Securities Proceeds
Usamriid Agreement Usg
Vaccine Injury Compensation Program Vaccine Production Cgmp Compliance
Vaccines Valid Claim
Valuer Vendor Contracts
Vivacs Gmbh Voting Agreement Between Biopharm Llc Biologika
Voting Agreement Dated 2004 Voting Securities Votes Required
Warranties Representations Wellcome Grant
Wellcome Trust Means Principal Place Business Located Gibbs Whereas
Winnersh 500 Witness
Witness Whereof Witnesses Follows
Zsolt Harsanyi Phd Age Became Director 2004 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki